Stroke, Vol 19, 217-222, Copyright © 1988 by American Heart Association
M Kakihana, N Fukuda, M Suno and A Nagaoka
The effects of cytidine 5'-diphosphocholine (CDP-choline) on neurologic
deficits and cerebral glucose metabolism were studied in a rat model of
transient cerebral ischemia. Cerebral ischemia was induced by occluding
both common carotid arteries for 20 or 30 minutes 24 hours after the
vertebral arteries were permanently occluded by electrocautery. CDP-
choline was administered intraperitoneally twice daily for 4 days after
reestablishing carotid blood flow. CDP-choline at two dosages (50 and 250
mg/kg) shortened the time required for recovery of spontaneous motor
activity in a dose-related manner; recovery time was measured early after
reperfusion. Neurologic signs were observed for 10 days. High-dose
CDP-choline improved neurologic signs in the rats within 20- 30 minutes of
ischemia. When cerebral glucose metabolism was assessed on Day 4, increases
in the levels of glucose and pyruvate were accompanied by decreases in the
synthesis of labeled acetylcholine from uniformly labeled [14C]glucose
measured in the cerebral cortex of rats with 30 minutes of ischemia.
High-dose CDP-choline also attenuated changes in these variables.
CDP-[1,2-14C]choline injected intravenously 10 minutes after reperfusion
was used for membrane lipid biosynthesis. These results indicate that
CDP-choline has beneficial effects on brain dysfunction induced by cerebral
ischemia, which may be due in part to the restorative effects of
CDP-choline on disturbed cerebral glucose metabolism, probably by
stimulating phospholipid biosynthesis.
ARTICLES
Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia
Biology Laboratories, Takeda Chemical Industries, Limited, Osaka, Japan.
This article has been cited by other articles:
![]() |
R. M. Adibhatla, J. F. Hatcher, E. C. Larsen, X. Chen, D. Sun, and F. H. C. Tsao CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke J. Biol. Chem., March 10, 2006; 281(10): 6718 - 6725. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Clark, L. R. Wechsler, L. A. Sabounjian, and U. E. Schwiderski A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients Neurology, November 13, 2001; 57(9): 1595 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Clark, B. J. Williams, K. A. Selzer, R. M. Zweifler, L. A. Sabounjian, and R. E. Gammans A Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke Stroke, December 1, 1999; 30(12): 2592 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Andersen, K. Overgaard, P. Meden, G. Boysen, and S. C. Choi Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model • Editorial Comment Stroke, July 1, 1999; 30(7): 1464 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Clark, L. Gunion-Rinker, N. Lessov, K. Hazel, and R. L. Macdonald Citicoline Treatment for Experimental Intracerebral Hemorrhage in Mice • Editorial Comment Stroke, October 1, 1998; 29(10): 2136 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Onal, F. Li, T. Tatlisumak, K. W. Locke, B. W. Sandage Jr, and M. Fisher Synergistic Effects of Citicoline and MK-801 in Temporary Experimental Focal Ischemia in Rats Stroke, May 1, 1997; 28(5): 1060 - 1065. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |